The COVID-19 pandemic induces very different reactions of people on the internet (https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm) and in the social networks. Without following the conspiracy theories as “5G nanochip hidden in COVID vaccines” some news as “COVID vaccines induce allergic reactions” should be scientifically recognised. The picture from the 5G-nanochip whose plan goes viral on the internet is now exposed as fake and shows a guitar pedal. Quite different the recent news about allergic responses after injection of the COVID vaccine [1-3]. Is it true, and how about nanoparticles in vaccines?
Firstly, we should know that the active ingredient within the new vaccines are very sensitive molecules (the so-called mRNA) which must not only be cooled during transport but also would immediately be degraded after injection if not explicitly be stabilized by a special nano-shell. Here the principles of nanomedicine are adopted as the instable RNA-molecule is packed into a lipid layer containing stabilizing polymers (e.g. polyethylene glycol = PEG and others) [4, 5]. These polymers are part of the transport system which delivers the active agent to the cells in our body which start the anti-viral machinery. Unfortunately, such molecules may have a disadvantage because a small part of the population responds sensitive to polymers such as PEG which has been observed in 12 patients after getting the vaccine [1, 3]. The portion of sensitive people is very small but not negligible (currently more than 32 Mio. people have been vasccinated, as of January 2021), thus, it is important to know about the ingredients [please find the full list of the two recent vaccines in 3] and to discuss these with the treating physician. Scientific fact is: the size of the lipid vesicles (nano) is not of importance in relation to adverse effects. Ingredients such as the polymers of the shell around the active agent may induce problems, but the advantage of a COVID vaccination is indisputable.
If someone wants to know more about nanoparticles and vaccination, please visit the website of the Helmholtz Centre for Infection Research: https://www.helmholtz-hzi.de/en/news-events/stories/vaccination-with-nanoparticles/ .
Literature:
- de Vrieze, J (2021) Pfizer’s vaccine raises allergy concerns. Science, 371(6524): 10-11.
- Kleine-Tebbe, J et al. (2021) Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences. Allergol Select, 5 26-28.
- Worm, M et al. (2021) Covid-19 vaccination and risk of anaphylaxis – Recommendations for practical management. MMW Fortschr Med, 163(1): 48-51.
- Editorial (2020) Nanomedicine and the COVID-19 vaccines. Nat Nanotechnol, 15(12): 963
- Abd Ellah, NH et al. (2020) Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine (Lond), 15(21): 2085-2102.
Weitere Spotlights
Spotlight October 2021: Nanopesticides – a proposal for a risk assessment framework
The application of so-called “nanopesticides” (see also cross-sectional text Nanomaterials in plant protection products) is said to have two basic advantages: a smaller amount of pesticide is needed for the same agricultural area and the efficacy is improved. This is necessary to grow enough food for a still growing world population. However, this could also […]
Read moreSpotlight January 2021: Nanoplastics challenge – How to improve tracking of nanopolystyrene distribution in the environment.
In January, we present a paper published in the Nature Journal communications materials. The article focuses on the development of a new detection method of nanopolystyrene. The method not only makes it possible to detect nanoplastics in the environment for the first time, but also to determine their accumulation in plants and animals. Nanoplastics, which […]
Read moreSpotlight September: A methodology for the automatic evaluation of data quality and completeness of nanomaterials for risk assessment purposes
This paper describes a method for automatically assessing the quality and completeness of nanosafety data for the purpose of risk assessment. Steps to develop the methodology for assessing data completeness and the methodology for assessing quality are presented. The methodology is tailored to physicochemical and hazard (meta) data, but can also be configured with appropriate […]
Read moreSpotlight August 2020: The nanoGRAVUR Grouping approach
In August, we would like to present a paper of the German BMBF project nanoGRAVUR. nanoGRAVUR dealt from 2015-2018 with the grouping of nanostructured materials with regard to occupational safety, consumer and environmental protection and risk mitigation. The approach is now described by the project partners in this paper.Due to the variety of synthetic nanomaterials and the numerous modifications (differences in size, shape, chemical composition and surface functionalization), the effort required to investigate effects and behaviour within the framework of regulatory requirements is…
Read more